Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

BUY
$224.73 - $338.64 $449,460 - $677,280
2,000 Added 15.38%
15,000 $3.71 Million
Q3 2021

Nov 12, 2021

SELL
$310.19 - $376.2 $620,380 - $752,400
-2,000 Reduced 13.33%
13,000 $4.23 Million
Q2 2021

Aug 10, 2021

SELL
$262.71 - $351.17 $1.05 Million - $1.4 Million
-4,000 Reduced 21.05%
15,000 $4.68 Million
Q1 2021

May 14, 2021

BUY
$285.92 - $355.13 $5.43 Million - $6.75 Million
19,000 New
19,000 $6.06 Million
Q4 2020

Feb 11, 2021

SELL
$251.88 - $324.2 $2.77 Million - $3.57 Million
-11,000 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$255.22 - $317.0 $2.04 Million - $2.54 Million
-8,000 Reduced 42.11%
11,000 $3.05 Million
Q2 2020

Aug 12, 2020

SELL
$141.4 - $257.09 $424,200 - $771,269
-3,000 Reduced 13.64%
19,000 $4.59 Million
Q1 2020

May 14, 2020

BUY
$130.51 - $196.01 $652,550 - $980,050
5,000 Added 29.41%
22,000 $3.19 Million
Q4 2019

Feb 10, 2020

SELL
$159.31 - $223.54 $882,577 - $1.24 Million
-5,540 Reduced 24.58%
17,000 $2.9 Million
Q3 2019

Nov 12, 2019

BUY
$175.89 - $279.23 $147,747 - $234,553
840 Added 3.87%
22,540 $4.01 Million
Q2 2019

Aug 14, 2019

SELL
$250.96 - $284.94 $1 Million - $1.14 Million
-4,000 Reduced 15.56%
21,700 $5.65 Million
Q1 2019

May 14, 2019

BUY
$276.39 - $362.25 $276,390 - $362,250
1,000 Added 4.05%
25,700 $7.34 Million
Q4 2018

Feb 12, 2019

BUY
$281.08 - $444.25 $281,080 - $444,250
1,000 Added 4.22%
24,700 $8.03 Million
Q3 2018

Nov 13, 2018

BUY
$354.53 - $449.75 $4.86 Million - $6.16 Million
13,700 Added 137.0%
23,700 $10.7 Million
Q2 2018

Aug 10, 2018

SELL
$278.07 - $446.21 $2.78 Million - $4.46 Million
-10,000 Reduced 50.0%
10,000 $4.09 Million
Q4 2017

Feb 09, 2018

BUY
$168.78 - $199.74 $1.35 Million - $1.6 Million
8,000 Added 66.67%
20,000 $3.75 Million
Q2 2017

Aug 14, 2017

BUY
N/A
12,000
12,000 $1.72 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.